These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6211524)
1. Lack of effect of 4-aminopyridine on choreic movements. Lundh H; Fehling C J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):274-5. PubMed ID: 6211524 [No Abstract] [Full Text] [Related]
2. Caution of use of 4-aminopyridine. Cozanitis DA; Jones CT Am J Hosp Pharm; 1983 Oct; 40(10):1620, 1622. PubMed ID: 6139017 [No Abstract] [Full Text] [Related]
3. Effects of 4-aminopyridine in elderly patients with Alzheimer's disease. Wesseling H; Agoston S; Van Dam GB; Pasma J; DeWit DJ; Havinga H N Engl J Med; 1984 Apr; 310(15):988-9. PubMed ID: 6366565 [No Abstract] [Full Text] [Related]
4. 4-Aminopyridine and haemodialysis in the treatment of verapamil intoxication. ter Wee PM; Kremer Hovinga TK; Uges DR; van der Geest S Hum Toxicol; 1985 May; 4(3):327-9. PubMed ID: 2989157 [TBL] [Abstract][Full Text] [Related]
5. [Effect of 4-aminopyridine on the development of experimental botulism]. Morrison VV; Kryzhanovskiĭ GN Biull Eksp Biol Med; 1985 Oct; 100(10):445-7. PubMed ID: 2996654 [TBL] [Abstract][Full Text] [Related]
6. Effects of 4-aminopyridine in patients with multiple sclerosis. Jones RE; Heron JR; Foster DH; Snelgar RS; Mason RJ J Neurol Sci; 1983; 60(3):353-62. PubMed ID: 6631441 [TBL] [Abstract][Full Text] [Related]
7. Effective treatment of verapamil intoxication with 4-aminopyridine in the cat. Agoston S; Maestrone E; van Hezik EJ; Ket JM; Houwertjes MC; Uges DR J Clin Invest; 1984 May; 73(5):1291-6. PubMed ID: 6538884 [TBL] [Abstract][Full Text] [Related]
8. Novel drug of choice in Eaton-Lambert syndrome. Lundh H; Nilsson O; Rosén I J Neurol Neurosurg Psychiatry; 1983 Jul; 46(7):684-5. PubMed ID: 6310051 [No Abstract] [Full Text] [Related]
9. [Rohypnol poisoning as a cause of postanesthetic coma and the success of 4-aminopyridine therapy]. Schmutzler S; Uges D; Agoston S; Langrehr D Anaesthesist; 1984 Jun; 33(6):294-5. PubMed ID: 6476337 [TBL] [Abstract][Full Text] [Related]
10. [Research progress on a new potassium channel-blocking agent--4-aminopyridine]. Zheng W; Zhang YP Sheng Li Ke Xue Jin Zhan; 1986 Jul; 17(3):254-8. PubMed ID: 2432655 [No Abstract] [Full Text] [Related]
11. [Effect 4-aminopyridine on the recovery of segmental reflexes after sectioning of the sciatic nerve in the rat]. Serdiuchenko IIa; Mantulo PM; Karneta IM Neirofiziologiia; 1986; 18(5):702-4. PubMed ID: 3022170 [TBL] [Abstract][Full Text] [Related]
12. 4-aminopyridine-a review. Soni N; Kam P Anaesth Intensive Care; 1982 May; 10(2):120-6. PubMed ID: 6285756 [TBL] [Abstract][Full Text] [Related]
13. Treatment of choreic movements with perphenazine. Fahn S Dis Nerv Syst; 1972 Oct; 33(10):653-8. PubMed ID: 4265163 [No Abstract] [Full Text] [Related]
14. 4-Aminopyridine improves clinical signs in multiple sclerosis. Stefoski D; Davis FA; Faut M; Schauf CL Ann Neurol; 1987 Jan; 21(1):71-7. PubMed ID: 2435223 [TBL] [Abstract][Full Text] [Related]
15. The use of aminopyridines in neurological disorders. Sedehizadeh S; Keogh M; Maddison P Clin Neuropharmacol; 2012; 35(4):191-200. PubMed ID: 22805230 [TBL] [Abstract][Full Text] [Related]
16. [Analgesic activity of pymadine]. Mitsov V; Bantutova I Farmakol Toksikol; 1988; 51(4):32-4. PubMed ID: 2847937 [TBL] [Abstract][Full Text] [Related]